首页> 外国专利> LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS.

LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS.

机译:拉喹莫德联合疗法治疗多发性硬化症。

摘要

The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I) : as described herein. The subject invention also provides packages and pharmaceutical compositions comprising laquinimod and a compound of formula (I) as described herein. The subject invention further provides uses of said compounds, pharmaceutical compositions and packages in treating a subject afflicted with a form of MS or presenting a CIS.
机译:本发明提供了一种治疗患有多发性硬化症(MS)形式或表现出临床孤立综合征(CIS)的受试者的方法,该方法包括向该受试者定期施用一定量的拉喹莫德和一定量的式(I)化合物:如此处所述。本发明还提供了包含拉喹莫德和本文所述的式(I)化合物的包装和药物组合物。本发明进一步提供了所述化合物,药物组合物和包装在治疗患有MS形式或患有CIS的受试者中的用途。

著录项

  • 公开/公告号MX2016003763A

    专利类型

  • 公开/公告日2016-10-28

    原文格式PDF

  • 申请/专利权人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;

    申请/专利号MX20160003763

  • 发明设计人 JOEL KAYE;VOLKER KNAPPERTZ;

    申请日2014-09-26

  • 分类号A61K31/225;

  • 国家 MX

  • 入库时间 2022-08-21 14:24:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号